Atlas Trials

A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment

Clinical trial NCT04811898 · COMPLETED

Trial details

NCT number
NCT04811898
Sponsor
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma, RefractoryHepatocarcinomaAdvanced Solid Tumor
Start date
2019-01-14
Primary completion
2021-12-29
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.